These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10599652)

  • 21. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial.
    Ciulla TA; Danis RP; Klein SB; Malinovsky VE; Soni PS; Pratt LM; Pugh NO; Morphis JG; Bloch C; Cameron J
    Am J Ophthalmol; 2002 Dec; 134(6):905-6. PubMed ID: 12470761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radiotherapy for choroidal neovascularization in age-related macular degeneration. A pilot study using low- versus high-dose photon bean radiation].
    Thölen AM; Meister A; Bernasconi PP; Messmer EP
    Ophthalmologe; 1998 Oct; 95(10):691-8. PubMed ID: 9828635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of radiation for age-related macular degeneration.
    Char DH; Irvine AI; Posner MD; Quivey J; Phillips TL; Kroll S
    Am J Ophthalmol; 1999 May; 127(5):574-8. PubMed ID: 10334351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study.
    Bellmann C; Unnebrink K; Rubin GS; Miller D; Holz FG
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):968-74. PubMed ID: 13680248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy.
    Hoeller U; Fuisting B; Schwartz R; Roeper B; Richard G; Alberti W
    Eye (Lond); 2005 Nov; 19(11):1151-6. PubMed ID: 15543182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report.
    Sasai K; Murata R; Mandai M; Takahashi M; Ogura Y; Ngata Y; Nishimura Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):173-8. PubMed ID: 9300752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.
    Fujii GY; de Juan E; Pieramici DJ; Humayun MS; Phillips S; Reynolds SM; Melia M; Schachat AP
    Am J Ophthalmol; 2002 Jul; 134(1):69-74. PubMed ID: 12095810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J
    Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External-beam radiation therapy for age-related macular degeneration: two years' follow-up results at a total dose of 20 Gy in 10 fractions.
    Churei H; Ohkubo K; Nakajo M; Hokotate H; Baba Y; Ideue J; Miyagawa K; Nakayama H; Hiraki Y; Kitasato T; Yabe N
    Radiat Med; 2004; 22(6):398-404. PubMed ID: 15648455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiation therapy of occult choroidal neovascularisation (CNV) in age-related macular degeneration (AMD)].
    Weinberger AW; Wolf S; Kube T; Solbach U; Dobberstein H; Schleicher UM; Kirchhof B
    Klin Monbl Augenheilkd; 1999 Feb; 214(2):96-9. PubMed ID: 10218202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.
    Bressler NM; Bressler SB; Hawkins BS; Marsh MJ; Sternberg P; Thomas MA;
    Am J Ophthalmol; 2000 Oct; 130(4):387-407. PubMed ID: 11024412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study.
    Jaakkola A; Heikkonen J; Tommila P; Laatikainen L; Immonen I
    Ophthalmology; 2005 Apr; 112(4):567-73. PubMed ID: 15808245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes.
    Kobayashi H; Kobayashi K
    Am J Ophthalmol; 2000 Nov; 130(5):617-35. PubMed ID: 11078841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
    Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
    Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial.
    Lewis H; VanderBrug Medendorp S
    Ophthalmology; 1997 Nov; 104(11):1847-51; discussion 1852. PubMed ID: 9373115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2.
    Stevenson MR; Hart PM; Chakravarthy U; Mackenzie G; Bird AC; Owens SL; Chisholm IH; Hall V; Houston RF; McCulloch DW; Plowman N
    Br J Ophthalmol; 2005 Aug; 89(8):1045-51. PubMed ID: 16024863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
    Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
    Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Japanese Age-Related Macular Degeneration Tial (JAT) Study Group
    Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.